- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Genzyme, a Sanofi Company
Total 1000 results
-
Duke UniversityGenzyme, a Sanofi CompanyRecruitingLate-Onset Pompe Disease | Lysosomal DiseaseUnited States
-
LMU KlinikumGenzyme, a Sanofi CompanyCompletedPompe DiseaseGermany, Taiwan, Italy
-
Emory UniversityGenzyme, a Sanofi CompanyCompleted
-
Duke UniversityGenzyme, a Sanofi CompanyActive, not recruitingPompe Disease (Late-onset) | Pompe Disease | GAA DeficiencyUnited States
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular DystrophyUnited States
-
Duke UniversityGenzyme, a Sanofi CompanyCompleted
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular Dystrophy | Becker Muscular DystrophyUnited States, United Kingdom
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular Dystrophy | Becker Muscular DystrophyUnited States, Belgium, Australia, Canada, France, Germany, Israel, Italy, Spain, Sweden, United Kingdom
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedHemophilia A | Hemophilia BUnited States, Canada, France, Italy
-
Stanford UniversityGenzyme, a Sanofi CompanyTerminatedLeukemia | Leukemia, Myeloid | Acute Myeloid Leukemia (AML)United States
-
Northwestern UniversityGenzyme, a Sanofi CompanyWithdrawnPROSTATE CANCERUnited States
-
Duke UniversityGenzyme, a Sanofi CompanyCompletedKidney Failure, Chronic | Hyperparathyroidism, SecondaryUnited States
-
Vanderbilt UniversityGenzyme, a Sanofi CompanyCompletedKidney TransplantationUnited States
-
Columbia UniversityGenzyme, a Sanofi CompanyRecruitingMonoclonal GammopathyUnited States
-
Duke UniversityGenzyme, a Sanofi CompanyRecruitingPompe DiseaseUnited States
-
Duke UniversityGenzyme, a Sanofi CompanyCompletedNeuropathy | Myopathy | Glycogen Storage Disease Type II (Late-onset Pompe Disease)United States
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedAmino Acid Metabolism, Inborn ErrorsFrance, United Kingdom, Italy, Belgium, Germany, Switzerland
-
Yale UniversityGenzyme, a Sanofi CompanyCompleted
-
Emory UniversityGenzyme, a Sanofi CompanyCompletedLymphoma | MyelomaUnited States
-
Duke UniversityGenzyme, a Sanofi CompanyCompletedMultiple Myeloma | Non-Hodgkins Lymphoma | Hodgkins DiseaseUnited States
-
Mayo ClinicGenzyme, a Sanofi CompanyCompletedKidney TransplantUnited States
-
Genzyme, a Sanofi CompanyManipal Acunova Ltd.Completed
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
Genzyme, a Sanofi CompanyMentor Worldwide, LLCCompletedFacial Wrinkles at the Nasolabial FoldsUnited States
-
Genzyme, a Sanofi CompanyCambridge Antibody TechnologyCompletedSystemic Sclerosis | SclerodermaUnited States
-
Johns Hopkins UniversityGenzyme, a Sanofi CompanyWithdrawnChronic Inflammatory Demyelinating NeuropathyUnited States
-
Jewish General HospitalGenzyme, a Sanofi CompanyWithdrawn
-
University of ChicagoGenzyme, a Sanofi CompanyCompleted
-
Hannover Medical SchoolGenzyme, a Sanofi CompanyUnknownAcute Myeloid LeukemiaGermany
-
Hannover Medical SchoolGenzyme, a Sanofi CompanyUnknownThyroid Neoplasms | Thyroid CarcinomaGermany
-
University of Wisconsin, MadisonSanofi; Genzyme, a Sanofi CompanyTerminatedProstate CancerUnited States
-
University of NebraskaGenzyme, a Sanofi CompanyCompletedEnd-stage Renal DiseaseUnited States
-
University of UtahGenzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States
-
University Hospital, BordeauxGenzyme, a Sanofi CompanyActive, not recruitingMultiple Sclerosis, Relapsing-RemittingFrance
-
University Hospital MuensterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
University Hospital, MontpellierGenzyme, a Sanofi CompanyTerminatedProgressive Multiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingFrance
-
The Cleveland ClinicGenzyme, a Sanofi CompanyCompletedLiver TransplantationUnited States
-
Ohio State UniversityGenzyme, a Sanofi CompanyCompleted
-
Hannover Medical SchoolGenzyme, a Sanofi CompanyUnknownAcute Myeloid Leukemia | MDSGermany
-
University of LiverpoolGenzyme, a Sanofi CompanyUnknownLymphoma | Lymphoproliferative Disorders | Multiple Myeloma | Plasma Cell DyscrasiaUnited Kingdom
-
Cabrini Medical CentreGenzyme, a Sanofi CompanyUnknownOsteoarthritisAustralia
-
University of WashingtonGenzyme, a Sanofi CompanyRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of AarhusGenzyme, a Sanofi CompanyCompletedMultiple SclerosisDenmark
-
NYU Langone HealthGenzyme, a Sanofi CompanyCompleted
-
University of MinnesotaGenzyme, a Sanofi CompanyWithdrawnNeuropathic Pain | Fabry DiseaseUnited States
-
Oncology Specialists, S.C.Genzyme, a Sanofi CompanyCompletedProstate CancerUnited States
-
University of ChicagoGenzyme, a Sanofi CompanyCompleted
-
Virginia Commonwealth UniversityGenzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous LeukemiaUnited States
-
Oncology Specialists, S.C.Genzyme, a Sanofi CompanyCompletedLymphoma, B-Cell | Lymphoma, Non-HodgkinUnited States
-
University of UtahGenzyme, a Sanofi CompanyTerminatedCancer | Chronic Myelomonocytic LeukemiaUnited States